[Fifty two-week chronic oral toxicity study of mofezolac (N-22) in rats]. 1990

K Satoh, and H Furukawa, and Y Nasu, and H Sone, and T Ichiki, and R Kodama, and M Kuwata, and K Yamashita
Panapharm Laboratories Co., Ltd., Kumamoto, Japan.

Fifty two-week oral toxicity study of mofezolac (N-22), a new developed analgesic and anti-inflammatory agent, was carried out in Wistar rats with dose levels of 5, 20, 60 and 120 mg/kg/day, and the 5-week withdrawal was followed for recovery study. Hematuria, blanching of the skin and suppression of body weight gain were observed in females given 120 mg/kg, and 9 of these prostrated and died from week 20 to week 52, or were euthanized when moribund. These symptoms were not seen in males at any dose levels. In 120 mg/kg group, increased positive cases of fecal occult blood were observed during the administration period, and the pathological examination revealed gastrointestinal lesions such as erosion, ulcer, hemorrhage and mucosal regeneration in the small intestine. Renal disorder was also involved mainly in females given 120 mg/kg, as shown by increase in urine volume with declined osmotic pressure and specific gravity, serum urea nitrogen, creatinine, inorganic phosphorus, and other related parameters. In addition to enlargement, rough surface and scar formation, dilated tubular lumen and papillary ducts of the kidney were observed as a main lesion. Incidental findings with those disorders, observed mainly in females given 120 mg/kg, included increase in leucocytes with high neutrophils ratio, and enlargement of the spleen, adrenals and mesenteric lymph node. There were some of the similar gastrointestinal and renal changes mainly in females given 60 mg/kg. Anemic findings were noted in both sexes of 120 mg/kg and in females of 60 mg/kg group, and mainly females given 120 mg/kg showed increase in platelets, reticulocytes and fibrinogen, shortening of blood coagulation time, as well as extramedullary or accented hematopoiesis of the liver, spleen and bone marrow. Other serum biochemical changes observed mainly in females given 120 mg/kg were decrease or decreasing trend in total protein, A/G ratio, and transaminase activity. Fine structure of the liver from females given 20 mg/kg or more revealed cisternal dilatation of smooth-surfaced endoplasmic reticulum of hepatocytes, and the increased liver weight was observed in females given 120 mg/kg. Accordingly, non-effective dose level of N-22 in 52-week chronic toxicity study was estimated to be 20 mg/kg for males and 5 mg/kg for females.

UI MeSH Term Description Entries
D007555 Isoxazoles Azoles with an OXYGEN and a NITROGEN next to each other at the 1,2 positions, in contrast to OXAZOLES that have nitrogens at the 1,3 positions. Isoxazole
D007674 Kidney Diseases Pathological processes of the KIDNEY or its component tissues. Disease, Kidney,Diseases, Kidney,Kidney Disease
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005260 Female Females
D005767 Gastrointestinal Diseases Diseases in any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM. Cholera Infantum,Gastrointestinal Disorders,Functional Gastrointestinal Disorders,Gastrointestinal Disorders, Functional,Disease, Gastrointestinal,Diseases, Gastrointestinal,Functional Gastrointestinal Disorder,Gastrointestinal Disease,Gastrointestinal Disorder,Gastrointestinal Disorder, Functional
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000740 Anemia A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN. Anemias

Related Publications

K Satoh, and H Furukawa, and Y Nasu, and H Sone, and T Ichiki, and R Kodama, and M Kuwata, and K Yamashita
June 1990, The Journal of toxicological sciences,
K Satoh, and H Furukawa, and Y Nasu, and H Sone, and T Ichiki, and R Kodama, and M Kuwata, and K Yamashita
June 1990, The Journal of toxicological sciences,
K Satoh, and H Furukawa, and Y Nasu, and H Sone, and T Ichiki, and R Kodama, and M Kuwata, and K Yamashita
May 1990, The Journal of toxicological sciences,
K Satoh, and H Furukawa, and Y Nasu, and H Sone, and T Ichiki, and R Kodama, and M Kuwata, and K Yamashita
June 1990, The Journal of toxicological sciences,
K Satoh, and H Furukawa, and Y Nasu, and H Sone, and T Ichiki, and R Kodama, and M Kuwata, and K Yamashita
May 1992, The Journal of toxicological sciences,
K Satoh, and H Furukawa, and Y Nasu, and H Sone, and T Ichiki, and R Kodama, and M Kuwata, and K Yamashita
June 1990, The Journal of toxicological sciences,
K Satoh, and H Furukawa, and Y Nasu, and H Sone, and T Ichiki, and R Kodama, and M Kuwata, and K Yamashita
June 1990, The Journal of toxicological sciences,
K Satoh, and H Furukawa, and Y Nasu, and H Sone, and T Ichiki, and R Kodama, and M Kuwata, and K Yamashita
June 1990, The Journal of toxicological sciences,
K Satoh, and H Furukawa, and Y Nasu, and H Sone, and T Ichiki, and R Kodama, and M Kuwata, and K Yamashita
June 1990, The Journal of toxicological sciences,
K Satoh, and H Furukawa, and Y Nasu, and H Sone, and T Ichiki, and R Kodama, and M Kuwata, and K Yamashita
June 1990, The Journal of toxicological sciences,
Copied contents to your clipboard!